All articles by Derek Lowe – Page 8
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
OpinionName reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
OpinionFear of the unknown
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
-
OpinionFull disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
-
Opinion
High finance meets big pharma?
Derek Lowe examines an alternative funding model for pharmaceutical research
-
-
-
-
-
OpinionPeace, love and understanding
Chemists and biologists often view the process of drug discovery very differently
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come
-
Opinion
Rewards of repurposing
Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about
-
-
Opinion
Compounds in the dark
Derek Lowe discusses the compounds you can buy but won't see anywhere in the literature
-
OpinionCommon sense and safety
You have to make space for good sense when thinking about safety, argues Derek Lowe
-
Opinion'Pay for delay'
Derek Lowe considers an increasingly popular business strategy in the drug industry, the much discussed 'pay for delay' deal
-
OpinionThe pitfalls that prevent progress
Derek Lowe highlights the less visible pitfalls on the road to a new drug